MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
AH Chen, YE Qin, WF Tang, J Tao, H Song… - Cancer cell …, 2017 - Springer
AH Chen, YE Qin, WF Tang, J Tao, H Song, M Zuo
Cancer cell international, 2017•SpringerBackground Recent evidence indicated that the aberrant expression of microRNA plays a
crucial role in the development of cervical cancer. The overall shorter survival was strongly
related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-
206), which target B cell lymphoma-2 (Bcl2) and c-Met. Hepatocyte growth factor (HGF)/c-
Met pathway is related to the occurrence, development and prognosis of cervical cancer,
and c-Met is significantly overexpressed in cervical squamous cell carcinoma. Bcl2 is also …
crucial role in the development of cervical cancer. The overall shorter survival was strongly
related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-
206), which target B cell lymphoma-2 (Bcl2) and c-Met. Hepatocyte growth factor (HGF)/c-
Met pathway is related to the occurrence, development and prognosis of cervical cancer,
and c-Met is significantly overexpressed in cervical squamous cell carcinoma. Bcl2 is also …
Background
Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell lymphoma-2(Bcl2) and c-Met. Hepatocyte growth factor (HGF)/c-Met pathway is related to the occurrence, development and prognosis of cervical cancer, and c-Met is significantly overexpressed in cervical squamous cell carcinoma. Bcl2 is also considered to be a promising target for developing novel anticancer treatments.
Methods
In this study, we detect the expression of miR-34a and miR-206 in the cervical cancer tissue through quantificational real-time polymerase chain reaction (qRT-PCR) assay, and the expression of Bcl2 and c-Met from cervical cancer tissue were detected by immunohistochemistry.
Results
The expression of miR-34a and miR-206 were down-regulated in the cervical cancer tissue through qRT-PCR assay. As target genes of miR-34a and miR-206, Bcl2 and c-Met were up-regulated in cervical cancer tissues through qRT-PCR assay and immunohistochemistry. Kaplan–Meier and log-rank analysis revealed that down-regulated expression of miR-34a and miR-206 were strongly related to shorter overall survival. Multivariate Cox proportional hazards model for all variables that were statistically significant in the univariate analysis demonstrated that miR-34a (P = 0.038) and miR-206 (P = 0.008) might be independent prognostic factors for overall survival of patients suffering from cervical cancer.
Conclusions
The up-regulation of Bcl2 and c-Met promotes the cervical cancer’s progress, and the expression of miR-34a and miR-206 significantly correlated with the progression and prognosis in cervical cancer. All of these suggested that miR-34a and miR-206 might be the novel prognostic and therapy tools in cervical cancer.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果